|
0 Companies |
|
0 Products |
|
0 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
18 News |
|
- ||| NN1213 / Novo Nordisk
Trial completion: Evaluating the Efficacy of Opti-Speech for Speech Treatment (clinicaltrials.gov) - Dec 31, 2018
P=N/A, N=37, Completed, Sponsor: Vulintus, Inc.
Recruiting --> Completed
- | Trial completion, Phase classification: Efficacy of Voice Treatment for Parkinson's Disease (clinicaltrials.gov) - Jul 31, 2018
P=N/A, N=620, Completed, Sponsor: University of Colorado, Boulder
Recruiting --> Completed Recruiting --> Completed | Phase classification: P2 --> PN/A
- | Trial completion, Trial primary completion date: ProdDiGYPark: Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease (clinicaltrials.gov) - May 18, 2017
P=N/A, N=70, Completed, Sponsor: University Hospital, Lille
Recruiting --> Completed | Phase classification: P2 --> PN/A Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Feb 2017
- Trial completion, Trial primary completion date: Intensive Dysarthria Sessions in Adults and Children With Down Syndrome (clinicaltrials.gov) - Nov 23, 2016
P=N/A, N=5, Completed, Sponsor: Duke University
Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Feb 2017 Active, not recruiting --> Completed | Trial primary completion date: Nov 2016 --> May 2016
- Enrollment closed: ProdDiGYPark: Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease (clinicaltrials.gov) - Jun 23, 2016
P=N/A, N=64, Active, not recruiting, Sponsor: University Hospital, Lille
Active, not recruiting --> Completed | Trial primary completion date: Nov 2016 --> May 2016 Recruiting --> Active, not recruiting
- New trial: Evaluating the Efficacy of Opti-Speech for Speech Treatment (clinicaltrials.gov) - Mar 10, 2016
P=N/A, N=30, Recruiting, Sponsor: Vulintus, Inc.
- Enrollment closed, Enrollment change, Trial primary completion date: Intensive Dysarthria Sessions in Adults and Children With Down Syndrome (clinicaltrials.gov) - Feb 2, 2016
P=N/A, N=3, Active, not recruiting, Sponsor: Duke University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | N=12 --> 3 | Trial primary completion date: Nov 2015 --> Nov 2016
- Trial primary completion date: ProdDiGYPark: Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease (clinicaltrials.gov) - Jan 20, 2016
P=N/A, N=64, Recruiting, Sponsor: University Hospital, Lille
Recruiting --> Active, not recruiting | N=12 --> 3 | Trial primary completion date: Nov 2015 --> Nov 2016 Trial primary completion date: Dec 2015 --> Dec 2017
- New trial: ProdDiGYPark: Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease (clinicaltrials.gov) - Dec 11, 2015
P=N/A, N=64, Recruiting, Sponsor: University Hospital, Lille
- Enrollment open: Intensive Dysarthria Sessions in Adults and Children With Down Syndrome (clinicaltrials.gov) - Aug 11, 2014
P=N/A, N=12, Recruiting, Sponsor: Duke University
Trial primary completion date: Dec 2015 --> Dec 2017 Not yet recruiting --> Recruiting
- Trial initiation date: Intensive Dysarthria Sessions in Adults and Children With Down Syndrome (clinicaltrials.gov) - Jan 23, 2014
P=N/A, N=12, Not yet recruiting, Sponsor: Duke University
Not yet recruiting --> Recruiting Initiation date: Aug 2013 --> Jan 2014
- Enrollment change: MJFFSpeech: Improve Speech Using an In-the-ear Device in Parkinson's Disease (clinicaltrials.gov) - Jan 16, 2013
P1, N=40, Completed, Sponsor: Rush University Medical Center
Initiation date: Aug 2013 --> Jan 2014 N=100 --> 40
- Trial completion: MJFFSpeech: Improve Speech Using an In-the-ear Device in Parkinson's Disease (clinicaltrials.gov) - Jan 16, 2013
P1, N=40, Completed, Sponsor: Rush University Medical Center
N=100 --> 40 Active, not recruiting --> Completed
- Clinical: Intensive Dysarthria Sessions in Adults and Children With Down Syndrome (clinicaltrials.gov) - Sep 11, 2012
P=N/A, N=12, Not yet recruiting, Sponsor: Duke University